Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gailani

Showing results (11-20 of 168) with videos related to

Pageof 17
Sort By:
Expert Review of Cardiovascular Therapy|July 4, 2007
Role of Factor XII in hemostasis and thrombosis: clinical implicationsThomas Renné, David Gailani
Current Opinion in Hematology|August 3, 2020
The rebirth of the contact pathway: a new therapeutic targetPriyanka Srivastava, David Gailani
Blood|December 24, 2023
Targeting factor XI and factor XIa to prevent thrombosisDavid Gailani, Andras Gruber
Seminars in Thrombosis and Hemostasis|September 13, 2017
Inhibition of Factors XI and XII for Prevention of Thrombosis Induced by Artificial SurfacesBenjamin Tillman, David Gailani
Research and Practice in Thrombosis and Haemostasis|July 25, 2025
A brief comparison of human factor XII-Ala<sup>188</sup> and factor XII-Pro<sup>188</sup>Aleksandr Shamanaev, David Gailani
Journal of Thrombosis and Haemostasis : JTH|November 4, 2021
A proposal for managing bleeding in patients on therapeutic factor XI(a) inhibitorsOphira Salomon, David Gailani
Arteriosclerosis, Thrombosis, and Vascular Biology|October 6, 2007
Intrinsic pathway of coagulation and arterial thrombosisDavid Gailani, Thomas Renné
Journal of Thrombosis and Haemostasis : JTH|December 5, 2019
Toward a better understanding of factor XI activationDavid Gailani, Jonas Emsley
Hematology/Oncology Clinics of North America|September 18, 2016
The Intrinsic Pathway of Coagulation as a Target for Antithrombotic TherapyAllison P Wheeler, David Gailani
Expert Review of Hematology|August 29, 2009
Update on the physiology and pathology of factor IX activation by factor XIaStephen B Smith, David Gailani
Pageof 17

Showing results (11-20 of 168) with videos related to

Sort By:
Pageof 17
Expert Review of Cardiovascular Therapy|July 4, 2007
Role of Factor XII in hemostasis and thrombosis: clinical implicationsThomas Renné, David Gailani
Current Opinion in Hematology|August 3, 2020
The rebirth of the contact pathway: a new therapeutic targetPriyanka Srivastava, David Gailani
Blood|December 24, 2023
Targeting factor XI and factor XIa to prevent thrombosisDavid Gailani, Andras Gruber
Seminars in Thrombosis and Hemostasis|September 13, 2017
Inhibition of Factors XI and XII for Prevention of Thrombosis Induced by Artificial SurfacesBenjamin Tillman, David Gailani
Research and Practice in Thrombosis and Haemostasis|July 25, 2025
A brief comparison of human factor XII-Ala<sup>188</sup> and factor XII-Pro<sup>188</sup>Aleksandr Shamanaev, David Gailani
Journal of Thrombosis and Haemostasis : JTH|November 4, 2021
A proposal for managing bleeding in patients on therapeutic factor XI(a) inhibitorsOphira Salomon, David Gailani
Arteriosclerosis, Thrombosis, and Vascular Biology|October 6, 2007
Intrinsic pathway of coagulation and arterial thrombosisDavid Gailani, Thomas Renné
Journal of Thrombosis and Haemostasis : JTH|December 5, 2019
Toward a better understanding of factor XI activationDavid Gailani, Jonas Emsley
Hematology/Oncology Clinics of North America|September 18, 2016
The Intrinsic Pathway of Coagulation as a Target for Antithrombotic TherapyAllison P Wheeler, David Gailani
Expert Review of Hematology|August 29, 2009
Update on the physiology and pathology of factor IX activation by factor XIaStephen B Smith, David Gailani
Pageof 17